A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Stopped Portfolio re-prioritization
Conditions
- Carcinoma, Renal Cell
- Kidney Diseases
- Kidney Neoplasms
- Urogenital Neoplasms
- Urologic Diseases
- Urologic Neoplasms
- Neoplasms by Histologic Type
- Neoplasms
- Clear-cell Metastatic Renal Cell Carcinoma
- Melanoma
- Triple Negative Breast Cancer
- Bladder Cancer
- Head and Neck Cancer
- Non-small Cell Lung Cancer
Interventions
- DRUG: Combination of Varlilumab and Atezolizumab
Sponsor
Celldex Therapeutics
Collaborators